Identification of PDGFRB as a prognostic immune-related biomarker in gastric cancer through bioinformatics and clinical analysis
The immune-related gene <i>PDGFRB</i> demonstrated significant prognostic value in GC and may serve as a potential biomarker for immune response modulation. Our findings highlight its association with tumor progression and tumor microenvironment characteristics, supporting its role in GC prognosis evaluation.
Authors
- Yuanan Liu (ORCID: https://orcid.org/0000-0002-8076-1904)
- Shujing Wang (ORCID: https://orcid.org/0000-0001-6806-253X)
- Bo Meng (ORCID: https://orcid.org/0000-0003-0433-5038)
- Qiang Wu (ORCID: https://orcid.org/0000-0002-8703-1728)
Institutions
- Anhui Medical University (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tcr-2025-859
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05